DNA testing company and former Silicon Valley Darling 23Andme filed for Chapter 11 bankruptcy protection and announced the resignation of co-founder and CEO Anwozicki.
TechCrunch Report Genetics Testing Giant 23AndMe filed for Chapter 11 bankruptcy protection in the US, marking a major recession for the companies it once recommended. This move comes as it looks to start selling assets to tackle financial and operational challenges. Breitbart News previously reported that the entire company's board of directors has resigned.
In addition to his bankruptcy filing, 23andme co-founder and CEO Anne Wojcicki has announced his resignation from the company. In a post on X (formerly Twitter), Wojcicki said, “While we have come to this conclusion and we are disappointed that our bid has been rejected, I will support the company and become a bidder.” Wojcicki's decision to resign as CEO allows her to pursue the company as an independent bidder in the court teacher sales process.
It is not clear how bankruptcy and an independent bid for Wojcicki to take over the company will affect the privacy of millions of customers.
Founded in 2006, 23andMe has become a prominent pioneer in the consumer DNA testing market, providing insights to its customers on genetic ancestry and health predispositions through saliva-based testing kits. However, the company has struggled to maintain its foothold in recent years, facing a series of set-offs that have seriously affected market value and profitability.
In 2021, 23AndMe was made public through a merger with a special purpose acquisition company (SPAC), and initially boasted a market capitalization of $6 billion. However, the company's value has since plummeted more than 99%, with stock trading at just $1.79 at the time of writing. This dramatic decline can be attributed to the company's inability to make profits and navigate an increasingly competitive market.
One of the most important blows against 23andMe came in 2023, when the company was victim of a massive cyber attack. Hackers were able to steal data from around 7 million customers, including sensitive information such as genetic predispositions and ancestral reports. The case further exacerbated the company's financial difficulties by bringing a $30 million settlement in a lawsuit related to the September 2024 data breaches.
In light of these challenges, the 23AndMe board's special committee determined that the court's supervisory sales process is the best way to maximize the value of the business. “We are pleased to announce that we are a member of the special committee,” said Mark Jensen, chairman and member of the special committee. “The court's oversight process hopes to advance efforts to address the operational and financial challenges we face, including further cost reductions and resolution of legal and lease liabilities.”
Bankruptcy filings and potential sale of 23andMe assets raise questions regarding the company's future and security of client genetic data. As the court's oversight process unfolds, it is still unclear whether the company will find the right buyer and whether Wojcicki's independent bid will be successful.
Please read more TechCrunch here.
Lucas Nolan is a reporter for Breitbart News, which covers the issues of freedom of speech and online censorship.
